Results 121 to 130 of about 53,957 (281)

Complications of polycystic kidney disease

Kidney International, 1997
A 33-year-old white man first presented to the Royal Infirmary Stirling, Scotland, 24 years ago with a history of recent-onset hematuria. Intravenous urography at that time showed a filling defect in the right kidney; a subsequent aortogram demonstrated a single simple cyst in the right kidney.
openaire   +2 more sources

Autosomal dominant polycystic kidney disease: updated perspectives

, 2019
Anjay Rastogi,1 Khalid Mohammed Ameen,1 Maha Al-Baghdadi,1 Kelly Shaffer,1 Niloofar Nobakht,1 Mohammad Kamgar,1 Edgar V Lerma21Department of Medicine, Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, USA; 2Department of Medicine,
Kamgar M, Al-Baghdadi M, Shaffer K, Lerma EV, Rastogi A, Nobakht N, Ameen KM   +6 more
core  

Healthcare costs of managing MAFLD are mostly driven by hospitalisation and advanced fibrosis: cost‐analysis from a tertiary‐care, multi‐disciplinary MAFLD clinic

Internal Medicine Journal, EarlyView.
Abstract Background and Aims Patients with metabolic (dysfunction)‐associated fatty liver disease (MAFLD) are frequently multimorbid, putting upward pressure on healthcare costs compared to other liver diseases. As Australian data are limited on expenditures in managing MAFLD, we evaluated hospital‐related costs and predictors of costs in patients ...
Natalie Ngu, Karl Vaz, Tobie Abrahams, Carmela Cosentino, John Lubel, Ammar Majeed, Stuart K Roberts, William Kemp   +7 more
wiley   +1 more source

Inspiring Tactics with the Improvement of Mitophagy and Redox Balance for the Development of Innovative Treatment against Polycystic Kidney Disease

Polycystic kidney disease (PKD) is the most common genetic form of chronic kidney disease (CKD), and it involves the development of multiple kidney cysts.
池田 祐香, Suga Naoko, 菅 尚子, Yoshikawa Sayuri, 1000050908168, Ikeda Yuka, Matsuda Satoru, すが なおこ, いけだ ゆか, Nakashima Moeka   +9 more
core   +1 more source

Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease

, 2018
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive enlargement of kidney cysts leading to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Identification of an early biomarker that can predict progression
Flessner, Michael F., Vicente E. Torres, Yu, Alan S.L., Mrug, Michal, Grantham, Jared J., Rahbari-Oskoui, Frederic F., Michal Mrug, Harris, Peter C., Torres, Vicente E., Bennett, William M., Kyongtae T. Bae, Frederic F. Rahbari-Oskoui, Chapman, Arlene B., Landsittel, Douglas P., William M. Bennett, Shen, Chengli, Chengli Shen, Bae, Kyongtae T., Jared J. Grantham, Alan S.L. Yu, Arlene B. Chapman, Peter C. Harris, Douglas P. Landsittel, Michael F. Flessner   +23 more
core   +1 more source

Growth‐regulating proteins differ between British seawater fish species, shedding light on their ecological adaptations

Journal of Fish Biology, EarlyView.
Abstract Wnt proteins are a family of molecules that help control how cells grow, develop and communicate – processes that are fundamental to the development and health of all animals. Although Wnt pathways have been studied extensively in model species, very little is known about how they operate in marine fish.
Angeliki Maravelia, Soniya Malik, Clare Murcott, Ioannis Batzakas, Paraskevi Goggolidou   +4 more
wiley   +1 more source

Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

, 2015
Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals and is the fourth most common cause for renal replacement therapy worldwide. There have been many recent advances in the understanding of its molecular genetics and
Torres, Vicente E., Walz, Gerd, Steinman, Theodore I., Perrone, Ronald D., Pirson, Yves, Emma, Francesco, Ecder, Tevfik, Mei, Changlin, Sandford, Richard, Harr, Nicole, Hogan, Marie C., Cowley, Benjamin, Onuchic, Luiz F., Obrador, Gregorio T., Eckardt, Kai Uwe, Mrug, Michal, Bichet, Daniel G., Martin, Rodolfo S., Jha, Vivek, Ahn, Curie, Pavia, Luisa Sternfeld, Flamion, Bruno, Aussilhou, Beatrice, Budde, Klemens, Lagrafeuil, Corinne, Winston, Kaori Yamane, Bergmann, Carsten, Watnick, Terry, Dell, Katherine M., Serra, Andreas L., Harris, Peter C., Férec, Claude, Winearls, Christopher G., Higashihara, Eiji, Galletti, Flavia, Rangan, Gopala K., Korst, Uwe, Torra, Roser, Ong, Albert C.M., Bae, Kyongtae T., Gitomer, Bernice, Devuyst, Olivier, Schrier, Robert W., Drenth, Joost P.H., Grantham, Jared J., De Coninck, Brenda, Alam, Ahsan, Strandgaard, Svend, Bennett, William M., Chapman, Arlene B., Horie, Shigeo, Chauveau, Dominique, Odland, Dwight, Hodouchi, Eiko, Gansevoort, Ron T., Harris, Tess, Pei, York, Wheeler, David C., Kasiske, Bertram L.   +58 more
core   +1 more source

Outcomes for Frail Dialysis Patients Not Referred for Transplantation: A Cohort Study

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Frailty is highly prevalent in kidney failure, but it is unclear whether frailty impacts health outcomes for those initiating dialysis who are not referred for transplantation. Our objective was to determine if frailty is associated with death or development of a permanent contraindication to transplantation among eligible non ...
Joshua Goodwin, Jordan Thorne, Amanda Vinson, David Clark, Bryce Kiberd, Micheal Sun, Karthik Tennankore   +6 more
wiley   +1 more source

ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non‐Attainment of CI Beta‐Lactam Therapy for Posttransplant Gram‐Negative Infections

Transplant Infectious Disease, EarlyView.
Augmented renal clearance (ARC) represents a quite prevalent condition among critical orthotopic liver transplant recipients (23.2%). ARC is associated with different demographics and clinical features and significantly affects the attainment of aggressive beta‐lactams pharmacokinetic/pharmacodynamic targets despite the administration of standard ...
Milo Gatti, Riccardo De Paola, Matteo Rinaldi, Cristiana Laici, Antonio Siniscalchi, Pierluigi Viale, Federico Pea   +6 more
wiley   +1 more source

Life on the list: an exploratory study of the life world of individuals waiting for a kidney transplant

, 2010
Kidney transplantation is the treatment of choice for many individuals with end stage renal disease (ESRD), as transplantation is reported to offer a greater quality of life than renal dialysis.
Long-Sutehall, Tracy, Frankland, Jane, Addington-Hall, Julia, Sque, Magi, Mason, Juan   +4 more
core